Heinrich-Braun-Klinikum Zwickau gGmbH
- Address
- Karl-Keil-Strasse 35, Marienthal, 08060 Zwickau, Germany
Heinrich-Braun-Klinikum Zwickau gGmbH - Hematology and Oncology Research Center
Heinrich-Braun-Klinikum Zwickau gGmbH is a comprehensive medical research facility with specialized expertise in hematological malignancies and critical care medicine. The center demonstrates particular strength in novel therapeutic approaches for blood cancers, including advanced targeted therapies and immunotherapies, while also conducting important research in acute care and infectious disease management.
- Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) with focus on tyrosine kinase inhibitors and bispecific antibody therapy
- Relapsed/refractory multiple myeloma utilizing novel bispecific T-cell engaging therapies
- Sepsis and peritonitis management with personalized immunoglobulin therapy approaches
The center's research portfolio reflects a commitment to personalized medicine and innovative treatment strategies across multiple disciplines. Their participation in multicenter trials evaluating ponatinib, blinatumomab, and teclistamab demonstrates expertise in cutting-edge therapeutic modalities for hematologic disorders. Additionally, their work in critical care addresses urgent clinical needs in patients with severe infections and multiple organ failure, combining interventional source control with targeted immunomodulatory treatments.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 4 therapeutic areas and 15 of 34 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Boehringer Ingelheim Espana S.A.1active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Heinrich-Braun-Klinikum Zwickau gGmbH
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Ponatinib vs. Imatinib with Low-Intensity Chemotherapy in Adults with De Novo Ph+ Acute Lymphoblastic Leukemia | Goethe University Frankfurt | Phase II | Recruiting | Jul 2023 | — |
IMP list
lock Showing 1 of 34 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amsacrine | 1 | Unknown | 2025-02-27 | 2025-02-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.